Cargando…
Biopharmaceutical innovation ecosystems: a stakeholder model and the case of Lombardy
The purpose of this paper is to examine biopharma innovation ecosystems (IEs) through the lenses of a stakeholder model. In doing so, this work aims to answer the following research question: which stakeholders are required in an IE within biopharma industry and what are their main roles in the IE v...
Autores principales: | Bettanti, Alberto, Lanati, Antonella, Missoni, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485311/ https://www.ncbi.nlm.nih.gov/pubmed/34611378 http://dx.doi.org/10.1007/s10961-021-09890-1 |
Ejemplares similares
-
CDMOs Play a Critical Role in the Biopharmaceutical Ecosystem
por: Kurata, Hideyuki, et al.
Publicado: (2022) -
Multispecific drugs: the fourth wave of biopharmaceutical innovation
por: Wang, Yifei, et al.
Publicado: (2020) -
Innovative Preparation of Biopharmaceuticals Using Transglycosylation Activity of Microbial Endoglycosidases
por: Katoh, Toshihiko, et al.
Publicado: (2021) -
Impact of government subsidies on innovation of Chinese biopharmaceutical firms: Based on kink threshold model
por: Li, Qing, et al.
Publicado: (2023) -
University–industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry
por: Tian, Mingyu, et al.
Publicado: (2021)